Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Protocols in Cytometry|April 4, 2017
Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle VioletPrashant Tembhare, Yajamanam Badrinath, Sitaram Ghogale, et al.
Indian Journal of Pathology & Microbiology|February 13, 2015
Blastic plasmacytoid dendritic cell neoplasm: report of two pediatric casesPreeti Ashok Dharmani, Neha Manish Mittal, P G Subramanian, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 17, 2015
A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotypingPrashant Tembhare, Yajamanam Badrinath, Sitaram Ghogale, et al.
Cytometry. Part B, Clinical Cytometry|January 10, 2018
Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathiesPrashant R Tembhare, Sitaram Ghogale, Wilma Tauro, et al.
Cytometry. Part B, Clinical Cytometry|September 1, 2020
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristicsDevasis Panda, Gaurav Chatterjee, Rohan Sardana, et al.
Indian Journal of Pathology & Microbiology|April 14, 2012
Morphological spectrum of leukemic mantle cell lymphomaKhaliqur Rahman, P G Subramanian, Pratibha Amare Kadam, et al.
Cytometry. Part B, Clinical Cytometry|August 2, 2020
Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia conditionDevasis Panda, Gaurav Chatterjee, Twinkle Khanka, et al.
Cytometry. Part B, Clinical Cytometry|January 17, 2020
CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemiaPratyusha Gudapati, Twinkle Khanka, Gaurav Chatterjee, et al.
Cytometry. Part B, Clinical Cytometry|October 9, 2016
Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000Prashant R Tembhare, Sitaram Ghogale, Nisha Ghatwai, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2020
Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusionPrashant R Tembhare, Gaurav Chatterjee, Twinkle Khanka, et al.
Pageof 2